Journal of Comprehensive Pediatrics

Published by: Kowsar

Microbial Colonization and Drug Resistance in Patients with Cystic Fibrosis

Soheila Khalilzadeh 1 , Mohamad Boloursaz 1 , Nooshin Baghaie 1 , Elaheh Heydarian Fard 1 , Maryam Hassanzad 1 , * and Habib Emami 2
Authors Information
1 Pediatric Respiratory Disease Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Tobacco Prevention and Control Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: August 14, 2012, 3 (1); 25-28
  • Published Online: August 14, 2012
  • Article Type: Research Article
  • Received: September 20, 2011
  • Revised: September 30, 2011
  • Accepted: October 10, 2011
  • DOI: 10.17795/compreped-6944

To Cite: Khalilzadeh S, Boloursaz M, Baghaie N, Heydarian Fard E, Hassanzad M, et al. Microbial Colonization and Drug Resistance in Patients with Cystic Fibrosis, J Compr Ped. 2012 ; 3(1):25-28. doi: 10.17795/compreped-6944.

Copyright © 2012, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Richard E, Behrman RMK, Hal B. Jenson Text book of Pediatrics. Boat.Cystic Fibrosis. 2004;
  • 2. Kabra SK, Kabra M, Shastri S, Lodha R. Diagnosing and managing cystic fibrosis in the developing world. Paediatr Respir Rev. 2006;7(Suppl 1):S147-50.;
  • 3. Fares F, David M, Lerner A, Diukman R, Lerer I, Abeliovich D, et al. Paternal isodisomy of chromosome 7 with cystic fibrosis and overgrowth. Am J Med Genet A. 2006; 140(16): 1785-8[DOI][PubMed]
  • 4. Marks JH. Airway clearance devices in cystic fibrosis. Paediatr Respir Rev. 2007; 8(1): 17-23[DOI][PubMed]
  • 5. Fields TM, Michel SJ, Butler CL, Kriss VM, Albers SL. Abdominal manifestations of cystic fibrosis in older children and adults. AJR Am J Roentgenol. 2006; 187(5): 1199-203[DOI][PubMed]
  • 6. Green A, Kirk J. Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis. Ann Clin Biochem. 2007; 44: 25-34[DOI][PubMed]
  • 7. Wall M. On staphylococcal prophylaxis in CF. Pediatr Pulmonol. 2007;42(2):186;; 42(2): 186[DOI][PubMed]
  • 8. Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther. 2006; 4(2): 261-75[DOI][PubMed]
  • 9. Kulczycki LL. Five decades of cystic fibrosis (1938-1988). Acta Univ Carol Med (Praha). 1990; 36(1-4): 7-12
  • 10. Therrell BL, Lloyd-Puryear MA, Mann MY. Understanding newborn screening system issues with emphasis on cystic fibrosis screening. J Pediatr. 2005; 147(3 Suppl)-10[DOI][PubMed]
  • 11. Katznelson D, Ben-Yishay M. Cystic fibrosis in Israel: clinical and genetic aspects. Isr J Med Sci. 1978; 14(2): 204-11[PubMed]
  • 12. Santana MA, Matos E, do Socorro Fontoura M, Franco R, Barreto D, Lemos AC. Prevalence of pathogens in cystic fibrosis patients in Bahia, Brazil. Braz J Infect Dis. 2003; 7(1): 69-72[DOI]
  • 13. Merqury N MJ. Clinical aspects of cystic fibrosis. Med Sci Monit. 2000; 11(12): 325-8
  • 14. Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL. Massive hemoptysis in cystic fibrosis. Chest. 2005; 128(2): 729-38[DOI][PubMed]
  • 15. Santamaria F, Grillo G, Guidi G, Rotondo A, Raia V, de Ritis G, et al. Cystic fibrosis: when should high-resolution computed tomography of the chest Be obtained? Pediatrics. 1998; 101(5): 908-13[DOI][PubMed]
  • 16. McIlwaine M. Chest physical therapy, breathing techniques and exercise in children with CF. Paediatr Respir Rev. 2007; 8(1): 8-16[DOI][PubMed]
  • 17. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology. 2007; 153: 917-23[DOI][PubMed]
  • 18. Ryan G, Mukhopadhyay S, Singh M. Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2003; (3)[PubMed]
  • 19. Ratjen F, Doring G, Nikolaizik WH. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet. 2001; 358(9286): 983-4[DOI]
  • 20. Ebert DL, Olivier KN. Nontuberculous mycobacteria in the setting of cystic fibrosis. Clin Chest Med. 2002; 23(3): 655-63[DOI]
  • 21. Adeboyeku D, Scott S, Hodson ME. Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis. J Cyst Fibros. 2006; 5(4): 261-3[DOI][PubMed]
  • 22. Hart CA, Winstanley C. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull. 2002; 61: 81-96[DOI][PubMed]
  • 23. Eftekhar F RF, Khodadad A. Evaluation of Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Iran J of Infection and Tropical Medicine. 2003; 20(8): 14-7
  • 24. Kim DN, Lazarus AA. Management of bronchiectasis. Dis Mon. 2008; 54(8): 540-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments